Literature DB >> 23074198

Function of carbonic anhydrase IX in glioblastoma multiforme.

Martin A Proescholdt1, Marsha J Merrill, Eva-Maria Stoerr, Annette Lohmeier, Fabian Pohl, Alexander Brawanski.   

Abstract

Carbonic anhydrase (CA) IX is over-expressed in glioblastoma; however, its functions in this context are unknown. Metabolically, glioblastomas are highly glycolytic, leading to a significant lactic acid load. Paradoxically, the intracellular pH is alkaline. We hypothesized that CAIX contributes to the extrusion of hydrogen ions into the extracellular space, thereby moderating intra- and extracellular pH and creating an environment conductive to enhanced invasion. We investigated the role of CAIX as a prognostic marker in patients with glioblastoma and its biological function in vitro. CAIX expression was analyzed in 59 patients with glioblastoma by immunohistochemistry. The expression levels were correlated to overall survival. In vitro, U251 and Ln 18 glioblastoma cells were incubated under hypoxia to induce CAIX expression, and RNA interference (RNAi) was used to examine the function of CAIX on cell attachment, invasion, intracellular energy transfer, and susceptibility to adjuvant treatment. High CAIX expression was identified as an independent factor for poor survival in patients with glioblastoma. In vitro, cell attachment and invasion were strongly reduced after knockdown of CAIX. Finally, the effects of radiation and chemotherapy were strongly augmented after CAIX interference and were accompanied by a higher rate of apoptotic cell death. CAIX is an independent prognostic factor for poor outcome in patients with glioblastoma. Cell attachment, invasion, and survival during adjuvant treatment are significantly influenced by high CAIX expression. These results indicate that inhibition of CAIX is a potential metabolic target for the treatment of patients with glioblastoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23074198      PMCID: PMC3480266          DOI: 10.1093/neuonc/nos216

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  42 in total

1.  Regulation of proliferation-survival decisions during tumor cell hypoxia.

Authors:  C Schmaltz; P H Hardenbergh; A Wells; D E Fisher
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

2.  Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure.

Authors:  S Oudard; E Boitier; L Miccoli; S Rousset; B Dutrillaux; M F Poupon
Journal:  Anticancer Res       Date:  1997 May-Jun       Impact factor: 2.480

3.  Transcriptional response to hypoxia in human tumors.

Authors:  A Lal; H Peters; B St Croix; Z A Haroon; M W Dewhirst; R L Strausberg; J H Kaanders; A J van der Kogel; G J Riggins
Journal:  J Natl Cancer Inst       Date:  2001-09-05       Impact factor: 13.506

4.  The catalytic properties of human carbonic anhydrase IX.

Authors:  T Wingo; C Tu; P J Laipis; D N Silverman
Journal:  Biochem Biophys Res Commun       Date:  2001-11-02       Impact factor: 3.575

5.  Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH.

Authors:  Eliska Svastová; Alzbeta Hulíková; Monika Rafajová; Miriam Zat'ovicová; Adriana Gibadulinová; Angela Casini; Alessandro Cecchi; Andrea Scozzafava; Claudiu T Supuran; Jaromír Pastorek; Silvia Pastoreková
Journal:  FEBS Lett       Date:  2004-11-19       Impact factor: 4.124

6.  Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships.

Authors:  R Opavský; S Pastoreková; V Zelník; A Gibadulinová; E J Stanbridge; J Závada; R Kettmann; J Pastorek
Journal:  Genomics       Date:  1996-05-01       Impact factor: 5.736

7.  P-31 MR spectroscopy of normal human brain and brain tumors.

Authors:  B Hubesch; D Sappey-Marinier; K Roth; D J Meyerhoff; G B Matson; M W Weiner
Journal:  Radiology       Date:  1990-02       Impact factor: 11.105

8.  Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment.

Authors:  J Pastorek; S Pastoreková; I Callebaut; J P Mornon; V Zelník; R Opavský; M Zat'ovicová; S Liao; D Portetelle; E J Stanbridge
Journal:  Oncogene       Date:  1994-10       Impact factor: 9.867

9.  Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion.

Authors:  Naomi Robertson; Christian Potter; Adrian L Harris
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

10.  High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss.

Authors:  S Oudard; F Arvelo; L Miccoli; F Apiou; A M Dutrillaux; M Poisson; B Dutrillaux; M F Poupon
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

View more
  53 in total

Review 1.  Zinc and zinc-containing biomolecules in childhood brain tumors.

Authors:  Jan Hrabeta; Tomas Eckschlager; Marie Stiborova; Zbynek Heger; Sona Krizkova; Vojtech Adam
Journal:  J Mol Med (Berl)       Date:  2016-09-16       Impact factor: 4.599

2.  ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres.

Authors:  Ulf D Kahlert; Abigail K Suwala; Eric H Raabe; Florian A Siebzehnrubl; Maria J Suarez; Brent A Orr; Eli E Bar; Jaroslaw Maciaczyk; Charles G Eberhart
Journal:  Brain Pathol       Date:  2015-02-08       Impact factor: 6.508

3.  Prognostic marker analysis in pediatric intracranial ependymomas.

Authors:  Roger E McLendon; Eric Lipp; Diane Satterfield; Melissa Ehinger; Alan Austin; Debra Fleming; Kathryn Perkinson; Michaela Lefaivre; David Zagzag; Benjamin Wiener; Sri Gururangan; Herbert Fuchs; Henry S Friedman; James E Herndon; Patrick Healy
Journal:  J Neurooncol       Date:  2015-01-07       Impact factor: 4.130

Review 4.  Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma.

Authors:  Mihaela Aldea; Ioan Alexandru Florian; Gabriel Kacso; Lucian Craciun; Sanda Boca; Olga Soritau; Ioan Stefan Florian
Journal:  Pharm Res       Date:  2016-05-26       Impact factor: 4.200

Review 5.  Is carbonic anhydrase IX a validated target for molecular imaging of cancer and hypoxia?

Authors:  Jianbo Li; Guojian Zhang; Xuemei Wang; Xiao-Feng Li
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

6.  Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma.

Authors:  Jing Cui; Qi Zhang; Qi Song; Herui Wang; Pauline Dmitriev; Mitchell Y Sun; Xiaoyu Cao; Yang Wang; Liemei Guo; Iris H Indig; Jared S Rosenblum; Chunxia Ji; Dongqing Cao; Kaiyong Yang; Mark R Gilbert; Yu Yao; Zhengping Zhuang
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300

7.  Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers.

Authors:  Peng-Cheng Lv; Karson S Putt; Philip S Low
Journal:  Bioconjug Chem       Date:  2016-07-07       Impact factor: 4.774

Review 8.  Disrupting proton dynamics and energy metabolism for cancer therapy.

Authors:  Scott K Parks; Johanna Chiche; Jacques Pouysségur
Journal:  Nat Rev Cancer       Date:  2013-09       Impact factor: 60.716

Review 9.  Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases.

Authors:  Narges K Tafreshi; Mark C Lloyd; Marilyn M Bui; Robert J Gillies; David L Morse
Journal:  Subcell Biochem       Date:  2014

10.  Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors.

Authors:  Peng-Cheng Lv; Jyoti Roy; Karson S Putt; Philip S Low
Journal:  Mol Pharm       Date:  2016-04-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.